+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Oncology Drugs Market Research Reports

Metastatic Triple-Negative Breast Cancer (mTNBC)- Pipeline Insight, 2025 - Product Thumbnail Image

Metastatic Triple-Negative Breast Cancer (mTNBC)- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Relapsed Or Refractory Myelodysplastic Syndrome - Pipeline Insight, 2025 - Product Thumbnail Image

Relapsed Or Refractory Myelodysplastic Syndrome - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
CAR T-Cell Therapy For Non-Hodgkin's Lymphoma- - Pipeline Insight, 2025 - Product Thumbnail Image

CAR T-Cell Therapy For Non-Hodgkin's Lymphoma- - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Lymphatic Malformations- - Pipeline Insight, 2025 - Product Thumbnail Image

Lymphatic Malformations- - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
From
Chemotherapy Induced Nausea And Vomiting - Pipeline Insight, 2025 - Product Thumbnail Image

Chemotherapy Induced Nausea And Vomiting - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
C-Met Mutated Non-small Cell Lung Cancer (NSCLC) - Pipeline Insight, 2025 - Product Thumbnail Image

C-Met Mutated Non-small Cell Lung Cancer (NSCLC) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Sphingosine 1 Phosphate Receptor Modulators - Pipeline Insight, 2025 - Product Thumbnail Image

Sphingosine 1 Phosphate Receptor Modulators - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Sezary Syndrome - Pipeline Insghts, 2025 - Product Thumbnail Image

Sezary Syndrome - Pipeline Insghts, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
C-MET Non-Small Cell Lung Cancer (c-MET+ NSCLC) - Pipeline Insight, 2025 - Product Thumbnail Image

C-MET Non-Small Cell Lung Cancer (c-MET+ NSCLC) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
T Cell Lymphoma -Pipeline Insight, 2025 - Product Thumbnail Image

T Cell Lymphoma -Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 250 Pages
  • Global
From
Advanced Endometrial Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

Advanced Endometrial Cancer - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Advanced Gastric Carcinoma - Pipeline Insight, 2025 - Product Thumbnail Image

Advanced Gastric Carcinoma - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 80 Pages
  • Global
From
Myelodysplastic Syndrome - Pipeline Insight, 2025 - Product Thumbnail Image

Myelodysplastic Syndrome - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 240 Pages
  • Global
From
Post-Polycythemia Vera Myelofibrosis - Pipeline Insight, 2025 - Product Thumbnail Image

Post-Polycythemia Vera Myelofibrosis - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 80 Pages
  • Global
From
T-Cell Acute Lymphoblastic Leukemia - Pipeline Insight, 2025 - Product Thumbnail Image

T-Cell Acute Lymphoblastic Leukemia - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Proto-oncogene Protein C Mdm2 Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Proto-oncogene Protein C Mdm2 Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Proto Oncogene Proteins C Pim 1 Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Proto Oncogene Proteins C Pim 1 Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Proto-oncogene Protein C-bcl-2 Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Proto-oncogene Protein C-bcl-2 Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Loading Indicator

The Oncology Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cancer. These drugs are used to treat a variety of cancers, including breast, lung, and prostate cancer. Oncology drugs are typically administered intravenously or orally, and can be used in combination with other treatments such as radiation and chemotherapy. The Oncology Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly researching and developing new drugs to treat cancer, as well as improving existing treatments. Additionally, many smaller companies are also involved in the Oncology Drugs market, providing innovative treatments and therapies. Show Less Read more